ClinicalTrials.Veeva

Menu

A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

Allergan logo

Allergan

Status and phase

Completed
Phase 3

Conditions

Migraine Disorders

Treatments

Drug: Placebo (Normal Saline)
Biological: Botulinum toxin type A Dose 2
Biological: Botulinum toxin type A Dose 1

Study type

Interventional

Funder types

Industry

Identifiers

NCT01662492
191622-103

Details and patient eligibility

About

To evaluate the efficacy and safety of Botulinum Toxin Type A versus placebo (normal saline) as headache prophylaxis in adolescents (children 12 to 17) with chronic migraine.

Enrollment

125 patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Medical history of chronic migraine for at least 6 months
  • 15 or more headache days during a 4 week period

Exclusion criteria

  • Previous use of any botulinum toxin of any serotype for any reason
  • Diagnosis of Myasthenia gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis
  • Treatment of headache using acupuncture, transcutaneous electrical stimulation (TENS), cranial traction, dental splints, or injection of anesthetics/steroids within 4 weeks prior to the week -4 screening visit
  • Use of any headache prophylaxis medication within 4 weeks prior to the week -4 screening visit

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

125 participants in 3 patient groups, including a placebo group

Botulinum toxin type A Dose 1
Experimental group
Description:
Botulinum toxin type A Dose 1 intramuscular injections into specified muscles.
Treatment:
Biological: Botulinum toxin type A Dose 1
Botulinum toxin type A Dose 2
Experimental group
Description:
Botulinum toxin type A Dose 2 intramuscular injections into specified muscles.
Treatment:
Biological: Botulinum toxin type A Dose 2
Placebo (Normal Saline)
Placebo Comparator group
Description:
Placebo (Normal Saline) intramuscular injections into specified muscles.
Treatment:
Drug: Placebo (Normal Saline)

Trial contacts and locations

22

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems